A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy

NCT ID: NCT01287897

Last Updated: 2016-01-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a proof of concept study to determine the efficacy and safety of a monoclonal antibody with three doses versus placebo. Subjects will be randomized to a treatment and the dose will be delivered subcutaneously twice, 4 weeks apart. All subjects will have moderate to severe refractory Crohn's Disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo- SC injection

Group Type PLACEBO_COMPARATOR

PF-04236921 SC injection

Intervention Type DRUG

Placebo delivered SC, 2 doses separated by 4 weeks

Drug Dose level 1 - SC injection

Group Type EXPERIMENTAL

PF-04236921 SC injection

Intervention Type DRUG

Drug dose level 1 delivered SC, 2 doses separated by 4 weeks

Drug Dose level 2 - SC injection

Group Type EXPERIMENTAL

PF-04236921 SC injection

Intervention Type DRUG

Drug dose level 2 delivered SC, 2 doses separated by 4 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PF-04236921 SC injection

Placebo delivered SC, 2 doses separated by 4 weeks

Intervention Type DRUG

PF-04236921 SC injection

Drug dose level 1 delivered SC, 2 doses separated by 4 weeks

Intervention Type DRUG

PF-04236921 SC injection

Drug dose level 2 delivered SC, 2 doses separated by 4 weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must have failed or are intolerant to anti TNFs
* hsCRP greater or equal to 5.0 mg/L
* Ulcerations demonstrated by colonoscopy as defined by SES CD assessment performed within 8 weeks of study entry (screening) and able to retrospectively complete the SES-CD or colonoscopy performed during screening

Exclusion Criteria

* Pregnant or breastfeeding women
* Crohn's Disease with active fistulae or abscess
* History of diverticulitis or symptomatic diverticulosis
* Abnormality in hematology or chemistry profiles at screening
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UAB Hospital

Birmingham, Alabama, United States

Site Status

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Simon Medical Imaging

Scottsdale, Arizona, United States

Site Status

Digestive Health Research Unit

Scottsdale, Arizona, United States

Site Status

Adobe Clinical Research, Llc

Tucson, Arizona, United States

Site Status

Radiology Ltd

Tucson, Arizona, United States

Site Status

UCSF Endoscopy Unit at Mount Zion

San Francisco, California, United States

Site Status

University of California - San Francisco

San Francisco, California, United States

Site Status

University of California San Francisco at Mount Zion

San Francisco, California, United States

Site Status

Rocky Mountain Clinical Research, LLC

Denver, Colorado, United States

Site Status

Rocky Mountain Gastroenterology Associates

Lakewood, Colorado, United States

Site Status

Rocky Mountain Gastroenterology

Lakewood, Colorado, United States

Site Status

Arapahoe Gastroenterology, PC

Littleton, Colorado, United States

Site Status

Endoscopy Center of Connecticut, LLC

Guilford, Connecticut, United States

Site Status

Endoscopy Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Gastroenterology Center of Connecticut, PC

Hamden, Connecticut, United States

Site Status

Medical Research Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Clinical Research of West Florida, Inc.

Clearwater, Florida, United States

Site Status

Gastroenterology Associates

Crystal River, Florida, United States

Site Status

Nature Coast Clinical Research

Inverness, Florida, United States

Site Status

Suncoast Endoscopy Center

Inverness, Florida, United States

Site Status

Advanced Research Institute, Inc.

New Port Richey, Florida, United States

Site Status

International Clinical Research - US, LLC

Sanford, Florida, United States

Site Status

Atlanta Center for Gastroenterology, P.C.

Decatur, Georgia, United States

Site Status

Atlanta Endoscopy Center

Decatur, Georgia, United States

Site Status

Decatur Health Imaging

Decatur, Georgia, United States

Site Status

Gastrointestinal Specialists of Georgia, PC

Marietta, Georgia, United States

Site Status

GI Diagnostics

Marietta, Georgia, United States

Site Status

Illinois Gastroenterology Group, LLC

Arlington Heights, Illinois, United States

Site Status

The University of Chicago Medical Center (Ucmc)

Chicago, Illinois, United States

Site Status

The University of Chicago Medical Center

Chicago, Illinois, United States

Site Status

The University of Chicago Medical

Chicago, Illinois, United States

Site Status

The University Of Chicago

Chicago, Illinois, United States

Site Status

NorthShore University Health System

Evanston, Illinois, United States

Site Status

Glenbrook Hospital Outpatient Pharmacy

Glenview, Illinois, United States

Site Status

Glenbrook Hospital

Glenview, Illinois, United States

Site Status

Central Indiana Gastroenterology Group

Anderson, Indiana, United States

Site Status

Saint John's Research Institute

Anderson, Indiana, United States

Site Status

University of Kentucky

Lexington, Kentucky, United States

Site Status

University Of Louisville Healthcare Outpatient Center

Louisville, Kentucky, United States

Site Status

University of Louisville Research Foundation

Louisville, Kentucky, United States

Site Status

University Of Louisville

Louisville, Kentucky, United States

Site Status

Digestive Disorders Associates

Annapolis, Maryland, United States

Site Status

Disgestive Disorders Associates

Annapolis, Maryland, United States

Site Status

Investigative Clinical Research

Annapolis, Maryland, United States

Site Status

Maryland Diagnostics & Therapeutic Endo Center

Annapolis, Maryland, United States

Site Status

Commonwealth Clinical Studies

Brockton, Massachusetts, United States

Site Status

Prima CARE, PC

Fall River, Massachusetts, United States

Site Status

St. Joseph Mercy Hospital

Ann Arbor, Michigan, United States

Site Status

East Valley Endoscopy

Grand Rapids, Michigan, United States

Site Status

Gastroenterology Associates of Western Michigan

Wyoming, Michigan, United States

Site Status

Metro Health Hospital Endoscopy Unit

Wyoming, Michigan, United States

Site Status

Metro Health Hospital

Wyoming, Michigan, United States

Site Status

Huron Gastroenterology Associates

Ypsilanti, Michigan, United States

Site Status

St. Joseph Mercy Hospital

Ypsilanti, Michigan, United States

Site Status

Minnesota Gastroenterology, PA

Plymouth, Minnesota, United States

Site Status

Weill Cornell Medical College of Cornell University-Greenberg

New York, New York, United States

Site Status

Weill Cornell Medical College of Cornell University

New York, New York, United States

Site Status

Present Chapman, Steinlauf and Marion

New York, New York, United States

Site Status

Mount Sinai School of Medicine

New York, New York, United States

Site Status

New York Presbyterian Hospital - Weill Cornell Medical College Investigational Pharmacy

New York, New York, United States

Site Status

New York Presbyterian Hospital

New York, New York, United States

Site Status

Weill Cornell Imaging at New York Presbyterian Hospital

New York, New York, United States

Site Status

Arthur asher Kornbluth, MD PC

New York, New York, United States

Site Status

PMG Research of Winston-Salem

Winston-Salem, North Carolina, United States

Site Status

Oklahoma Foundation for Digestive Research

Oklahoma City, Oklahoma, United States

Site Status

Pharmacy: Wheeler and Stuckey, Inc.

Oklahoma City, Oklahoma, United States

Site Status

Colonoscopy and X-rays: OU Physicians Building

Oklahoma City, Oklahoma, United States

Site Status

Hillcrest Medical Center Endoscopy

Tulsa, Oklahoma, United States

Site Status

Hillcrest Medical Center

Tulsa, Oklahoma, United States

Site Status

Options Health Research, LLC

Tulsa, Oklahoma, United States

Site Status

Utica Park Clinic X-Ray

Tulsa, Oklahoma, United States

Site Status

Advanced Imaging

Tulsa, Oklahoma, United States

Site Status

Pittsburgh Gastroenterology Associates

Pittsburgh, Pennsylvania, United States

Site Status

Research Protocol Management Specialists

Pittsburgh, Pennsylvania, United States

Site Status

Pharma Resource

East Providence, Rhode Island, United States

Site Status

Omega Medical Research

Warwick, Rhode Island, United States

Site Status

Gastro One

Germantown, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Professional Quality Research, Inc.

Austin, Texas, United States

Site Status

Diagnostic Clinic of Houston, PA

Houston, Texas, United States

Site Status

Houston Hospital for Specialized Surgery (Endoscopy Only)

Houston, Texas, United States

Site Status

Baylor Clinic (Drug Storage)

Houston, Texas, United States

Site Status

Baylor College of Medicine - Baylor Medical Center

Houston, Texas, United States

Site Status

Ertan Digestive Disease Center

Houston, Texas, United States

Site Status

Memorial Hermann Hospital

Houston, Texas, United States

Site Status

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

The University of Texas Medical School at Houston

Houston, Texas, United States

Site Status

Physicians Endoscopy Center (Colonoscopy)

Houston, Texas, United States

Site Status

Texas Digestive Disease Consultants

Southlake, Texas, United States

Site Status

One Step Diagnostic (X-Ray)

Sugar Land, Texas, United States

Site Status

Pioneer Research Solutions, Inc. (Admin. Office)

Sugar Land, Texas, United States

Site Status

Pioneer Research Solutions, Inc.

SugarLand, Texas, United States

Site Status

Digestive Health Specialists of Tyler

Tyler, Texas, United States

Site Status

University Of Utah HSC

Salt Lake City, Utah, United States

Site Status

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

VCU Medical Investigational Drug Service (IDS)

Richmond, Virginia, United States

Site Status

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Site Status

Nepean Public Hospital

Kingswood, New South Wales, Australia

Site Status

Royal Brisbane and Women's Hospital

Herston, Brisbane, Queensland, Australia

Site Status

Mater Health Services

South Brisbane, Queensland, Australia

Site Status

Eastern Health, Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

Monash Medical Centre

Clayton, Victoria, Australia

Site Status

The Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

St. Vincent's Hospital Melbourne

Fitzroy, , Australia

Site Status

University Hospital Leuven

Leuven, Vlaams Brabant, Belgium

Site Status

CHU Saint-Pierre

Brussels, , Belgium

Site Status

UZ Leuven Pharmacy

Leuven, , Belgium

Site Status

An Spiessens H.-Hartziekenhuis Roeselare-Menen vzw

Roeselare, , Belgium

Site Status

Clinica do Coracao Samaritano

Goiânia, Goiás, Brazil

Site Status

Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda.

Goiânia, Goiás, Brazil

Site Status

Center X Diagnosticos

Goiânia, Goiás, Brazil

Site Status

Hospital Universitário Fraga Filho da UFRJ

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Hospital Sao Lucas da PUCRS

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Faculdade de Medicina do ABC

Santo André, São Paulo, Brazil

Site Status

Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil

Site Status

Hospital Nossa Senhora das Gracas

Curitiba, , Brazil

Site Status

Heritage Medical Research Clinic - University of Calgary

Calgary, Alberta, Canada

Site Status

London Health Science Centre - University Hospital

London, Ontario, Canada

Site Status

Mount Sinai Hospital

Toronto, Ontario, Canada

Site Status

McGill University Health Centre - Royal Victoria Hospital

Montreal, Quebec, Canada

Site Status

Klinicke centrum ISCARE I.V.F. - gastroenterologie

Prague, Prague, Czechia

Site Status

Hepato-Gastroenterologie HK, s.r.o.

Hradec Králové, , Czechia

Site Status

Medial Pharma s.r.o.,

Hradec Králové, , Czechia

Site Status

Fakultni nemocnice Olomouc

Olomouc, , Czechia

Site Status

Fakultni nemocnice Kralovske Vinohrady

Prague, , Czechia

Site Status

Institut klinicke a experimentalni mediciny

Prague, , Czechia

Site Status

IBD Clinical and Research centre

Prague, , Czechia

Site Status

Krajska zdravotni, a.s.

Ústí nad Labem, , Czechia

Site Status

Aalborg Sygehus

Aalborg, , Denmark

Site Status

Aarhus Universitetshospital, Aarhus Sygehus Aarhus University Hospital

Aarhus C, , Denmark

Site Status

Rigshospitalet

Copenhagen, , Denmark

Site Status

Gastroenheden

Herlev, , Denmark

Site Status

Kirurgisk Afdeling 0143

Hilleroed, , Denmark

Site Status

Hvidovre Hospital

Hvidovre, , Denmark

Site Status

Afdeling I, Gastroenterologisk Sektion

Koebenhavn NV, , Denmark

Site Status

Medicinsk Afdeling, Gastroenterologisk Sektion

Koege, , Denmark

Site Status

Hopital Huriez, CHRU de Lille

Lille, , France

Site Status

Hopital Saint-Antoine - Service De Gastroenterologie

Paris, , France

Site Status

Hopital de Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany

Site Status

"Charite - Campus Benjamin Franklin

Berlin, , Germany

Site Status

Praxis Dr. Howaldt

Hamburg, , Germany

Site Status

Universitaetsklinikum Schleswig-Holstein

Kiel, , Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Minden

Minden, , Germany

Site Status

Universitaetsklinik Regensburg

Regensburg, , Germany

Site Status

University General Hospital "Attikon"

Athens, , Greece

Site Status

General Hospital of Athens "Evangelismos",1st Gastroenterology Department

Kolonaki Athens, , Greece

Site Status

Semmelweis Egyetem II. Sz. Belgyogyaszati Klinika

Budapest, , Hungary

Site Status

Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak./I. Belgyogyaszati-Gasztroenterologiai

Budapest, , Hungary

Site Status

Pannonia Maganorvosi Centrum Kft.

Budapest, , Hungary

Site Status

Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum

Debrecen, , Hungary

Site Status

Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar / I. sz. Belgyogyaszati Klinika

Szeged, , Hungary

Site Status

Clinfan Kft.

Szekszárd, , Hungary

Site Status

Beaumont Hospital

Dublin, , Ireland

Site Status

National Virus Reference Laboratory

Dublin, , Ireland

Site Status

Pathology, Haematology and Biochemistry Laboratories, St Vincent's Healthcare Group

Dublin, , Ireland

Site Status

Mater Misericordiae Hospital, Department of Clinical Chemistry and Clinical Haematology

Dublin, , Ireland

Site Status

St. Vincents University Hospital

Dublin, , Ireland

Site Status

University Hospital Galway

Galway, , Ireland

Site Status

The Institute Of Gastroenterology & Liver Diseases

Tel Litwinsky, Ramat Gan, Israel

Site Status

Institute of Gastroenterology

Haifa, , Israel

Site Status

The E. Wolfson Medical Center

Holon, , Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Hadassah Medical Center

Jerusalem, , Israel

Site Status

Dept of Gastroenterology & Hepatology

Kfar Saba, , Israel

Site Status

Rabin Medical Center, Beilinson Hospital

Petah Tikva, , Israel

Site Status

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Assaf Harofeh Medical Center

Ẕerifin, , Israel

Site Status

Casa Sollievo della Sofferenza/Div.Gastroenterologia Endoscopia Digestiva

San Giovanni Rotondo Fg, Foggia, Italy

Site Status

Istituto Clinico Humanitas IRCCS

Rozzano, Milano, Italy

Site Status

Azienda Ospedaliera - Universita di Padova

Padua, Padova, Italy

Site Status

A. Gemelli University Hospital-Department of Medical Sciences - Division of Internal Medicine and

Rome, Province of Rome, Italy

Site Status

Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola Malpighi

Bologna, , Italy

Site Status

Università Campus Biomedico

Roma, , Italy

Site Status

Policlinico Tor Vergata

Roma, , Italy

Site Status

Azienda Ospedaliera San Camillo Forlanini

Roma, , Italy

Site Status

Shakespeare Specialist Group

Milford, Auckland, New Zealand

Site Status

Christchurch Hospital

Christchurch, Canterbury, New Zealand

Site Status

Department of Gastroenterology Research

Hamilton, Waikato Region, New Zealand

Site Status

P3 Research Limited

Wellington, , New Zealand

Site Status

Spitalul Clinic Colentina

Bucharest, Sector 2, Romania

Site Status

Universitaetsspital Zuerich

Zurich, , Switzerland

Site Status

Hull and East Yorkshire Hospitals NHS Trust

Hull, East Yorkshire, United Kingdom

Site Status

Addenbrooke's Hospital, Department of Gastroenterology

Cambridge, , United Kingdom

Site Status

Glasgow Royal Infirmary

Glasgow, , United Kingdom

Site Status

Pharmacy Department

Hull, , United Kingdom

Site Status

Barts and The London NHS Trust

London, , United Kingdom

Site Status

Royal Free Hospital (Royal Free London NHS Foundation Trust)

London, , United Kingdom

Site Status

Royal Victoria Hospital

Newcastle upon Tyne, , United Kingdom

Site Status

New Cross Hospital

Wolverhampton, , United Kingdom

Site Status

Newcross Hospital-The Royal Wolverhampton Hospitals NHS Trust

Wolverhampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Brazil Canada Czechia Denmark France Germany Greece Hungary Ireland Israel Italy New Zealand Romania Switzerland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Li C, Shoji S, Beebe J. Pharmacokinetics and C-reactive protein modelling of anti-interleukin-6 antibody (PF-04236921) in healthy volunteers and patients with autoimmune disease. Br J Clin Pharmacol. 2018 Sep;84(9):2059-2074. doi: 10.1111/bcp.13641. Epub 2018 Jun 25.

Reference Type DERIVED
PMID: 29776017 (View on PubMed)

Danese S, Vermeire S, Hellstern P, Panaccione R, Rogler G, Fraser G, Kohn A, Desreumaux P, Leong RW, Comer GM, Cataldi F, Banerjee A, Maguire MK, Li C, Rath N, Beebe J, Schreiber S. Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II). Gut. 2019 Jan;68(1):40-48. doi: 10.1136/gutjnl-2017-314562. Epub 2017 Dec 15.

Reference Type DERIVED
PMID: 29247068 (View on PubMed)

Related Links

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-023034-23

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

ANDANTE

Identifier Type: OTHER

Identifier Source: secondary_id

B0151003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

B0151005 Open-Label Extension Study
NCT01345318 COMPLETED PHASE2